Siga Technologies INC Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
Siga Technologies INC (SIGA) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $998.65 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2026-03-10
- Siga Technologies INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2025 was $998.65K, a 126.86% increase from fiscal 2024.
- Siga Technologies INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2024 was $440.21K, a 8991.45% increase from fiscal 2023.
- Siga Technologies INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2023 was $4.84K, a 98.87% decline from fiscal 2022.
- Siga Technologies INC unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2022 was $430.25K.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2025-12-31 | $998.65K 10-K · filed 2026-03-10 |
| 2024-12-31 | $440.21K 10-K · filed 2026-03-10 |
| 2023-12-31 | $4.84K 10-K · filed 2026-03-10 |
| 2022-12-31 | $430.25K 10-K · filed 2025-03-11 |
| 2021-12-31 | $0.00 10-K · filed 2024-03-12 |
| 2020-12-31 | $0.00 10-K · filed 2023-03-02 |
| 2019-12-31 | $0.00 10-K · filed 2022-03-03 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |